Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kusstatscher

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Orvosi Hetilap|July 9, 1995
[Role of endogenous basic fibroblast growth factor in experimental duodenal ulcer]Z Sándor, S Kusstatscher, G Sakoulas, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1995
Molecular and cellular basis of ulcer healingS Szabo, S Kusstatscher, Z Sandor, et al.
Orvosi Hetilap|May 14, 1995
[The effect of thrombocyte-derived growth factor on experimental inflammatory bowel disease]Z Sándor, S Kusstatscher, D Szeli, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1995
Stimulation of mucosal glutathione and angiogenesis: new mechanisms of gastroprotection and ulcer healing by sucralfateZ Sandor, M Nagata, S Kusstatscher, et al.
The Journal of Clinical Investigation|August 15, 1996
Role of cysteine proteases and protease inhibitors in gastric mucosal damage induced by ethanol or ammonia in the ratL Nagy, S Kusstatscher, P V Hauschka, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Different molecular forms of basic fibroblast growth factor (bFGF) accelerate duodenal ulcer healing in ratsS Kusstatscher, Z Sandor, S Szabo, et al.
Minerva Chirurgica|April 15, 1991
[Collection, survey and interpretation of pH-metry data]G Mastropaolo, G Liberati, S Kusstatscher, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1995
Growth factors: new 'endogenous drugs' for ulcer healingS Szabo, S Kusstatscher, G Sakoulas, et al.
The American Journal of Gastroenterology|May 1, 1997
Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcerL Herszènyi, M Plebani, P Carraro, et al.
Journal of Gastroenterology and Hepatology|May 7, 1998
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: one or two weeks?N Dal Bo', F Di Mario, G Battaglia, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Orvosi Hetilap|July 9, 1995
[Role of endogenous basic fibroblast growth factor in experimental duodenal ulcer]Z Sándor, S Kusstatscher, G Sakoulas, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1995
Molecular and cellular basis of ulcer healingS Szabo, S Kusstatscher, Z Sandor, et al.
Orvosi Hetilap|May 14, 1995
[The effect of thrombocyte-derived growth factor on experimental inflammatory bowel disease]Z Sándor, S Kusstatscher, D Szeli, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1995
Stimulation of mucosal glutathione and angiogenesis: new mechanisms of gastroprotection and ulcer healing by sucralfateZ Sandor, M Nagata, S Kusstatscher, et al.
The Journal of Clinical Investigation|August 15, 1996
Role of cysteine proteases and protease inhibitors in gastric mucosal damage induced by ethanol or ammonia in the ratL Nagy, S Kusstatscher, P V Hauschka, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Different molecular forms of basic fibroblast growth factor (bFGF) accelerate duodenal ulcer healing in ratsS Kusstatscher, Z Sandor, S Szabo, et al.
Minerva Chirurgica|April 15, 1991
[Collection, survey and interpretation of pH-metry data]G Mastropaolo, G Liberati, S Kusstatscher, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1995
Growth factors: new 'endogenous drugs' for ulcer healingS Szabo, S Kusstatscher, G Sakoulas, et al.
The American Journal of Gastroenterology|May 1, 1997
Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcerL Herszènyi, M Plebani, P Carraro, et al.
Journal of Gastroenterology and Hepatology|May 7, 1998
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: one or two weeks?N Dal Bo', F Di Mario, G Battaglia, et al.
Pageof 2